news-med.jpg

Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates

The creation of LAB031 is designed to translate academic research into drug discovery candidates Evotec aims to generate multiple lead candidates for Sanofi over three years across multiple therapeutic categories

Topics: Corporate, Evotec, Sanofi, LAB031, BRIDGE Read More

Most Read

Posts by Topic